Mobile contingency management as an adjunctive treatment for co-morbid cannabis use disorder and cigarette smoking.
Mobile contingency management as an adjunctive treatment for co-morbid cannabis use disorder and cigarette smoking.
复制标题
DOI：
10.1016/j.addbeh.2017.12.007
复制
发表时间：
2018-04
影响因子：
4.4
通讯作者：
Calhoun PS
中科院分区：
文献类型：
--
作者：
Beckham JC;Adkisson KA;Hertzberg J;Kimbrel NA;Budney AJ;Stephens RS;Moore SD;Calhoun PS
大麻是美国使用最广泛的非法药物，目前有1980万用户。基于人口的数据表明，几乎所有大麻使用者（90%）都有终生吸烟史，大多数（74%）目前吸烟。在大麻使用者中，吸烟与大麻使用频率增加，发病率增加和大麻戒烟结果较差有关。然而，缺乏研究，重点是解决同时停止使用这两种物质。目前试点研究的目的是评价多成分烟草/大麻戒断治疗的可行性和可接受性。五名参与者完成了禁欲强化治疗，这是一种干预措施，包括五次烟草/大麻的认知行为电话咨询，戒烟药物治疗，以及五周的移动的应急管理，以保持对烟草和大麻的禁欲。招募、保留和完成治疗的可行性很高。对治疗的满意度也很高。结果支持大麻和烟草双重使用者的这种方法的可行性和可接受性，并建议进一步研究这种方法的有效性是必要的。
Cannabis is the most widely used illicit drug in the U.S. with 19.8 million current users. Population-based data indicate that almost all cannabis users (90%) have a lifetime history of tobacco smoking and the majority (74%) currently smoke tobacco. Among cannabis users, smoking tobacco is associated with increased frequency of cannabis use, increased morbidity, and poorer cannabis cessation outcomes. There is a lack of research, however, focused on addressing cessation of both substances simultaneously. The purpose of the current pilot study was to evaluate the feasibility and acceptability of a multi-component tobacco/cannabis abstinence treatment. Five participants completed Abstinence Reinforcement Therapy, an intervention that included five sessions of cognitive-behavioral telephone counseling for tobacco/cannabis, pharmacotherapy for smoking cessation, and five weeks of mobile contingency management to remain abstinent from tobacco and cannabis. Feasibility of recruitment, retention and treatment completion was high. Satisfaction with the treatment was also high. Results support the feasibility and acceptability of this approach with dual cannabis and tobacco users and suggest that further research examining the efficacy of this approach is warranted.
登录
查看更多内容
影响因子：
9.6
作者：
Bars, MP;Banauch, GI;Prezant, DJ
通讯作者：
Prezant, DJ
影响因子：
4.2
作者：
Allsop, David J.;Dunlop, Adrian J.;Copeland, Jan
通讯作者：
Copeland, Jan
DOI：
10.3109/00952990.2011.598592
发表时间：
2012-01
期刊：
The American journal of drug and alcohol abuse
影响因子：
--
作者：
Dallery J;Raiff B
通讯作者：
Raiff B
DOI：
10.1111/j.1360-0443.2012.03837.x
发表时间：
2012-07
期刊：
Addiction (Abingdon, England)
影响因子：
--
作者：
Agrawal A;Budney AJ;Lynskey MT
通讯作者：
Lynskey MT
DOI：
10.1186/1747-597x-8-33
发表时间：
2013-09-12
期刊：
Substance abuse treatment, prevention, and policy
影响因子：
--
作者：
Becker J;Hungerbuehler I;Berg O;Szamrovicz M;Haubensack A;Kormann A;Schaub MP
通讯作者：
Schaub MP